| Literature DB >> 28808829 |
Ellisiv L Jacobsen1, Asta Bye2,3, Nina Aass4,5, Sophie D Fosså5,6, Kjersti S Grotmol2, Stein Kaasa5,7, Jon Håvard Loge2,4, Torbjørn Moum8, Marianne J Hjermstad2,7.
Abstract
PURPOSE: Reference values for patient-reported outcome measures are useful for interpretation of results from clinical trials. The study aims were to collect Norwegian SF-36 reference values and compare with data from 1996 to 2002.Entities:
Keywords: General population; HRQoL; Quality of life; Reference values; SF-36; Stability
Mesh:
Year: 2017 PMID: 28808829 PMCID: PMC5891566 DOI: 10.1007/s11136-017-1684-4
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
Fig. 1Flowchart of subject inclusion in the three survey
Basic characteristics, responders, and non-responders in 2015
| Variables | Responders ( | Non-responders ( |
|
|---|---|---|---|
| Age, mean (±SD) | 55.7 (±14.1) | 47.7 (±15.1) | <.001* |
| Age groups, | <.001** | ||
| ≤29 years | 105 (5.0) | 492 (12.7) | |
| 30–39 years | 203 (9.6) | 806 (20.8) | |
| 40–49 years | 403 (19.0) | 873 (22.6) | |
| 50–59 years | 484 (22.9) | 738 (19.1) | |
| 60–69 years | 525 (24.8) | 581 (15.0) | |
| ≥70 years | 398 (18.8) | 380 (9.8) | |
| Gender, | |||
| Female | 1149 (54.2) | 1862 (48.1) | <.001** |
| Male | 947 (44.7) | 1928 (49.8) | |
* Independent sample t test ** X 2 test *Missing data: [N, (%)]: Respondents: Gender: N = 22, (1). Non-responders: Gender: N = 80 (2.1)
Reliability estimates from the 2015 survey, Cronbach’s alpha for the SF-36 scales, the percentage of subjects with minimum and maximum scores and correlations between the scales
| Scale | No. of items | Cronbach’s alpha | %Min./Max. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. PF | 10 | .91 | 0.5/33.3* | – | |||||||
| 2. RP | 4 | .90 | 15.0/63.7* | .643 | – | ||||||
| 3. BP | 2 | .90 | 0.9/28.5* | .523 | .608 | – | |||||
| 4. GH | 5 | .81 | 0.1/5.0 | .588 | .604 | .573 | – | ||||
| 5. VT | 4 | .83 | 0.9/2.1 | .432 | .496 | .508 | .630 | – | |||
| 6. SF | 2 | .85 | 0.8/60.2* | .455 | .513 | .451 | .573 | .610 | – | ||
| 7. RE | 3 | .83 | 5.9/80.2* | .325 | .399 | .304 | .382 | .420 | .544 | – | |
| 8. MH | 5 | .79 | 0.01/6.1 | .239 | .276 | .314 | .464 | .647 | .637 | .532 | – |
PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health, Min. minimum, Max. maximum
* Ceiling effect, all correlations were significant (p < .001)
Mean SF-36 scale scores (±SD) in 2015 by gender and age group, N = 2118
| Scales | Age groups | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18–29 years | 30–39 years | 40–49 years | 50–59 years | 60–69 years | 70–80 years | Total | ||||||||
| W ( | M ( | W ( | M ( | W ( | M ( | W ( | M ( | W ( | M ( | W ( | M ( | W ( | M ( | |
| PF | 93.2 (±14.7) | 97.6 (±6.2) | 94.0 (±10.2) | 94.8 (±9.6) | 90.7 (±16.8) | 92.8 (±12.6) | 87.9 (±16.1) | 90.0 (±16.3) | 80.8 (±22.6) | 85.7 (±18.4) | 71.6 (±26.9) | 80.3 (±19.3) | 84.9 (±21.0) | 88.1 (±17.0) |
| RP | 78.3 (±37.8) | 94.4 (±18.0) | 87.9 (±26.1) | 90.7 (±24.5) | 77.8 (±37.5) | 86.1 (±29.9) | 73.4 (±39.3) | 82.5 (±32.7) | 71.1 (±40.1) | 77.0 (±36.1) | 57.0 (±43.8) | 63.1 (±41.9) | 72.6 (±39.6) | 78.9 (±35.3) |
| BP | 72.7 (±27.0) | 83.5 (±19.1) | 76.0 (±23.0) | 78.8 (±24.8) | 67.0 (±27.5) | 71.7 (±26.3) | 66.4 (±25.5) | 72.4 (±24.8) | 64.2 (±26.8) | 71.7 (±25.2) | 63.5 (±26.7) | 67.8 (±25.9) | 66.9 (±26.5) | 72.1 (±25.4) |
| GH | 74.8 (±21.3) | 75.6 (±21.2) | 75.2 (±20.3) | 73.5 (±20.2) | 75.1 (±22.9) | 74.5 (±22.0) | 72.8 (±22.8) | 74.1 (±20.9) | 70.7 (±22.6) | 72.9 (±21.9) | 69.6 (±22.7) | 71.1 (±18.1) | 72.6 (±22.5) | 73.4 (±20.8) |
| VT | 47.6 (±19.6) | 58.3 (±18.7) | 54.4 (±19.1) | 57.8 (±16.8) | 56.3 (±19.5) | 58.8 (±18.5) | 56.1 (±20.8) | 62.2 (±18.5) | 60.5 (±20.8) | 64.0 (±20.3) | 60.3 (±21.0) | 63.3 (±18.2) | 57.2 (±20.6) | 61.9 (±18.9) |
| SF | 80.8 (±25.2) | 86.4 (±18.7) | 84.9 (±24.3) | 90.1 (±19.2) | 85.3 (±22.1) | 89.4 (±21.0) | 85.1 (±21.3) | 89.7 (±19.1) | 87.6 (±19.4) | 90.4 (±18.4) | 86.5 (±21.5) | 86.1 (±19.5) | 85.7 (±21.6) | 89.0 (±19.3) |
| RE | 78.6 (±33.6) | 79.6 (±35.8) | 86.6 (±29.7) | 92.5 (±21.0) | 88.2 (±28.7) | 93.4 (±22.9) | 91.6 (±22.0) | 91.63 (±23.5) | 89.2 (±27.5) | 89.9 (±26.1) | 82.4 (±33.3) | 83.7 (±31.2) | 87.4 (±28.6) | 89.5 (±26.3) |
| MH | 74.5 (±16.0) | 75.5 (±15.6) | 75.8 (±15.6) | 78.2 (±13.2) | 78.6 (±15.9) | 80.0 (±12.7) | 80.2 (±13.8) | 81.5 (±13.6) | 82.1 (±14.0) | 83.9 (±14.2) | 82.5 (±13.8) | 84.0 (±13.4) | 79.9 (±14.8) | 81.9 (±13.8) |
PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health, W women, M men
Basic characteristics of the respondents in 1996, 2002, and 2015, N = 9682
| Variables | 1996 | 2002 | 2015 |
|
|---|---|---|---|---|
| Response rate | 2323 (67) | 5241 (56) | 2118 (36) | |
| Age (years) | ||||
| Mean (±SD) | 44.9 (±16.5) | 47.4 (±16.9) | 55.5 (±14.1) | <.001* |
| Min.–Max. | 19–80 | 18–96 | 18–79 | |
| Age groups, | ||||
| ≤29 years | 510 (22.0) | 870 (16.6) | 105 (5.0) | |
| 30–39 years | 487 (21.0) | 1016 (19.4) | 203 (9.6) | |
| 40–49 years | 446 (19.2) | 1080 (20.6) | 403 (19.0) | |
| 50–59 years | 363 (15.6) | 980 (18.5) | 484 (22.9) | |
| 60–69 years | 283 (12.2) | 657 (12.9) | 525 (24.8) | |
| ≥70 years | 234 (10.1) | 620 (11.8) | 398 (18.8) | |
| Gender, | ||||
| Female | 1192 (51.3) | 2698 (51.5) | 1149 (54.2) | .023** |
| Male | 1131 (48.7) | 2543 (48.5) | 947 (44.7) | |
| Education, | ||||
| Second level, first stage | 621 (27.0) | 765 (14.6) | 377 (17.9) | <.001** |
| Second level, second stage | 1036 (45.0) | 2910 (55.5) | 782 (37.1) | |
| Third level (university college or university) | 643 (28.0) | 1503 (28.7) | 949 (45.0) | |
| Living situation, | ||||
| Alone | – | – | 358 (16.9) | |
| With children | – | – | 632 (29.8) | |
| With other adults | – | – | 1127 (53.2) | |
Missing data: 1996 [N, (%)]: education: 23 (1.0), 2002 [N, (%)]: education: 63 (1.2%), 2015 [N, (%)]: gender: 22 (1.0), education: 10 (0.5), living situation: 1 (<0.001), * One-way ANOVA ** X2
Multivariable regression models and associations between SF-36 scales scores and background variables
| PF | RP | BP | GH | VT | SF | RE | MH | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ( | ( | ( | ( | ( | ( | ( | ( | |||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||||
| B |
|
| B |
|
| B |
|
| B |
|
|
|
|
| B |
|
| B |
|
| B |
|
| |
| 1996 (ref) | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 2002 | −0.91 | −.02 | .043 | −1.32 | −.01 | .145 | −1.76 | −.03 | .006 | −1.80 | −.04 | .001 | 0.19 | .00 | .702 | 0.19 | .00 | .718 | 1.81 | .02 | .021 | 0.99 | .03 | .011 |
| 2015 | 2.41 | .05 | <.001 | 2.29 | .02 | .040 | −4.6 | −.07 | <.001 | −2.43 | −.04 | <.001 | −2.0 | −.04 | .001 | 1.48 | .02 | .025 | 7.40 | .09 | <.001 | 0.57 | .01 | .241 |
| Age groups | ||||||||||||||||||||||||
| <29 years | 3.23 | .05 | <.001 | 4.23 | .04 | <.001 | 5.18 | .07 | <.001 | 2.36 | .03 | <.001 | −1.84 | −.03 | .004 | 0.48 | .00 | .461 | −2.22 | −.02 | .019 | −1.67 | −.03 | .001 |
| 30–49 years (ref) | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 50–64 years | −6.58 | −.14 | <.001 | −8.36 | −.09 | <.001 | −4.92 | −.08 | <.001 | −5.31 | −.10 | <.001 | 1.48 | .03 | .006 | −0.67 | −.01 | .224 | −1.59 | −.02 | .048 | 1.80 | .05 | <.001 |
| 65–96 years | −17.35 | −.35 | <.001 | −24.61 | −.26 | <.001 | −6.53 | −.10 | <.001 | −8.71 | −.15 | <.001 | 2.18 | .04 | <.001 | −2.99 | −.05 | <.001 | −11.24 | −.14 | <.001 | 3.48 | .09 | <.001 |
| Education | . | |||||||||||||||||||||||
| Second level, first stage (ref) | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Second level, second stage | 6.81 | .17 | <.001 | 8.85 | .11 | <.001 | 4.95 | .09 | <.001 | 5.64 | .12 | <.001 | 3.67 | .08 | <.001 | 4.43 | .10 | <.001 | 8.25 | .13 | <.001 | 3.37 | .10 | <.001 |
| Third level | 11.21 | .26 | <.001 | 15.24 | .19 | <.001 | 11.47 | .20 | <.001 | 10.29 | .22 | <.001 | 6.03 | .13 | <.001 | 6.94 | .15 | <.001 | 11.18 | .16 | <.001 | 4.46 | .13 | <.001 |
| Gender | ||||||||||||||||||||||||
| Women (ref) | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Men | 4.31 | .10 | <.001 | 6.06 | .08 | <.001 | 4.7 | .09 | <.001 | 1.62 | .03 | <.001 | 5.2 | .12 | <.001 | 3.26 | .07 | <.001 | 4.01 | .06 | <.001 | 1.89 | .06 | <.001 |
B unstandardized beta, β standardized beta, PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health
Missing: N: MH: N = 272, VT: N = 234, BP: N = 163, GH: N = 454, SF: N = 137, PF: N = 252, RP: N = 262, RE: N = 357
Estimated means of SF-36 scale scores and 99% CIs by age group and survey, adjusted for education and gender, N = 9682
| Subscales | 18–29 years | 30–49 years | 50–64 years | 65–96 years | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1996 | 2002 | 2015 | 1996 | 2002 | 2015 | 1996 | 2002 | 2015 | 1996 | 2002 | 2015 | |
| PF, mean | 93.0 | 93.4 | 92.4 | 90.3 | 90.2 | 90.0 | 84.7 | 82.6 | 85.8* | 72.5 | 69.7 | 78.7* |
| 99% CI | 91.0–95.0 | 91.7–95.0 | 87.9–96.9 | 88.8–91.8 | 89.1–91.2 | 88.1–91.8 | 82.6–86.8 | 81.4–83.9 | 84.1–87.5 | 70.1–75.0 | 68.2–71.3 | 76.9–80.4 |
|
| 502 | 850 | 102 | 911 | 2062 | 598 | 472 | 1332 | 697 | 337 | 893 | 674 |
| RP, mean | 85.1 | 86.6 | 80.6 | 83.2 | 81.3 | 80.3 | 75.1 | 72.5 | 74.6 | 53.8 | 52.8 | 65.8* |
| 99% CI | 81.0–89.2 | 83.3–89.8 | 71.7–89.5 | 80.1–86.2 | 79.2–83.4 | 76.5–84.1 | 71.0–79.3 | 70.0–75.0 | 71.2–78.1 | 48.7–58.9 | 49.8–55.8 | 62.3–69.2 |
|
| 499 | 848 | 103 | 905 | 2062 | 597 | 467 | 1329 | 698 | 322 | 897 | 675 |
| BP, mean | 80.6 | 80.2 | 74.2 | 76.3 | 74.9 | 69.1* | 72.2 | 68.6 | 67.3 | 68.4 | 67.0 | 66.6 |
| 99% CI | 77.7–83.6 | 77.9–82.5 | 67.8–80.6 | 74.2–78.5 | 73.4–76.4 | 66.4–71.8 | 69.3–75.2 | 66.8–70.4 | 64.9–69.8 | 65.0–71.9 | 64.8–69.1 | 64.1–69.1 |
|
| 505 | 850 | 103 | 920 | 2064 | 598 | 489 | 1336 | 702 | 356 | 914 | 682 |
| GH, mean | 81.7 | 79.2 | 72.9* | 79.0 | 77.6 | 72.1* | 72.2 | 71.3 | 71.5 | 68.3 | 65.8 | 70.9* |
| 99% CI | 79.3–84.2 | 77.2–81.1 | 67.5–78.3 | 77.2–80.8 | 76.3–78.8 | 69.8–74.4 | 69.7–74.7 | 69.8–72.8 | 69.4–73.6 | 65.2–71.3 | 63.9–67.6 | 68.8–73.0 |
|
| 496 | 844 | 100 | 906 | 2048 | 586 | 456 | 1311 | 682 | 315 | 844 | 640 |
| VT, mean | 58.0 | 58.5 | 50.9* | 60.1 | 60.2 | 55.6* | 60.9 | 61.5 | 58.9 | 60.7 | 60.4 | 62.5 |
| 99% CI | 55.6–60.4 | 56.6–60.4 | 45.7–56.1 | 58.4–61.8 | 59.0–61.5 | 53.4–57.8 | 58.6–63.3 | 60.1–63.0 | 56.9–60.9 | 57.9–63.6 | 58.7–62.2 | 60.4–64.5 |
|
| 504 | 850 | 102 | 922 | 2062 | 598 | 482 | 1328 | 702 | 350 | 876 | 672 |
| SF, mean | 85.8 | 88.0 | 81.1 | 86.0 | 86.9 | 85.4 | 86.2 | 85.3 | 86.8 | 83.3 | 81.1 | 87.5* |
| 99% CI | 83.4–88.2 | 86.0–89.9 | 76.4–87.1 | 84.2–87.8 | 85.6–88.1 | 83.1–87.6 | 83.8–88.6 | 83.8–86.8 | 84.7–88.8 | 80.4–86.1 | 79.3–82.9 | 85.5–89.6 |
|
| 506 | 851 | 103 | 928 | 2067 | 598 | 492 | 1339 | 702 | 367 | 912 | 680 |
| RE, mean | 79.8 | 85.8 | 76.5 | 83.9 | 86.7 | 87.1 | 84.5 | 83.6 | 88.6 | 71.5 | 69.9 | 86.4* |
| 99% CI | 76.3–83.3 | 83.1–88.6 | 68.8–84.2 | 81.3–86.5 | 84.8–88.5 | 83.9–90.4 | 80.9–88.2 | 81.5–85.8 | 85.7–91.6 | 67.1–75.9 | 67.2–72.5 | 83.4–89.4 |
|
| 497 | 848 | 102 | 899 | 2052 | 597 | 461 | 1321 | 698 | 312 | 875 | 663 |
| MH, mean | 76.4 | 77.7 | 74.3 | 78.3 | 79.3 | 77.3 | 79.0 | 81.0 | 80.6 | 81.9 | 81.4 | 83.4 |
| 99% CI | 74.6–78.2 | 76.3–79.1 | 70.4–78.2 | 77.0–79.6 | 78.3–80.2 | 75.7–79.0 | 77.2–80.8 | 79.9–82.1 | 79.1–82.2 | 79.7–84.0 | 80.0–82.7 | 81.8–84.9 |
|
| 504 | 850 | 103 | 922 | 2060 | 598 | 479 | 1328 | 702 | 339 | 859 | 666 |
PF physical functioning, RP role physical, BP bodily pain, GH general health, VT vitality, SF social functioning, RE role emotional, MH mental health
* p < .01